| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aytu Biopharma, Inc (AYTU) has 9 insiders with recent SEC Form 4 filings, including 9 buys and 6 sells. AYTU is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.82M | $12.04M | - | |
| CEO | 184.7K | $461.8K | - | |
| Other | 61.6K | $153.9K | - | |
| Other | 36.1K | $90.3K | - | |
| CFO | 32.2K | $80.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 9, 2025 | Disbrow Jarrett | Chief Business Officer | Buy | 16,666 | $1.50 | $24,999.00 | +130.2% | +7.6% | - | |
| Jun 9, 2025 | Disbrow Joshua R.56 | Chief Executive Officer | Buy | 66,666 | $1.50 | $99,999.00 | +77.0% | +7.6% | - | |
| Feb 28, 2025 | Disbrow Joshua R.56 | Chief Executive Officer | Buy | 15,000 | $1.30 | $19,500.00 | +21.0% | +41.9% | +99.2% | |
| Jun 16, 2023 | Pyszczymuka Greg | Chief Commerical Officer | Buy | 12,000 | $1.87 | $22,428.00 | +120.8% | -15.9% | +56.6% | |
| Jun 14, 2023 | Disbrow Joshua R.56 | Chief Executive Officer | Buy | 14,000 | $1.86 | $26,079.20 | +24.3% | -7.4% | +64.0% | |
| Dec 19, 2022 | Disbrow Joshua R.56 | Chief Executive Officer | Buy | 112,371 | $0.22 | $25,047.50 | +10.0% | -53.3% | -33.9% | |
| Dec 19, 2022 | Pyszczymuka Greg | Chief Commercial Officer | Buy | 100,000 | $0.24 | $24,480.00 | +121.9% | -53.3% | -33.9% | |
| Dec 11, 2020 | Armistice Capital, LLC56 | Director | Buy | 1,333,334 | $6.00 | $8,000,004.00 | +100.0% | - | - | |
| Apr 27, 2020 | Armistice Capital, LLC56 | Director | Sale+OE | 5,108,921 | $1.82 | $9,298,236.22 | -100% | - | - | |
| Mar 10, 2020 | Armistice Capital, LLC56 | Director | Sale+OE | 22,026,801 | $1.42 | $31,200,122.91 | -81.8% | - | - |